Discontinued — last reported Q1 '21
Stryker Impairment Charges increased by 32.7% to $73.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 3550.0%, from $2.00M to $73.00M. Over 2 years (FY 2022 to FY 2024), Impairment Charges shows an upward trend with a 90.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Frequent or large impairment charges signal poor capital allocation or overly optimistic historical valuations of assets.
Impairment charges represent the write-down of the carrying value of assets when their fair value falls below their book...
Common in cyclical industries where asset values are highly sensitive to external market price assumptions.
is_impairment_charges| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $67.50M | $67.50M | $67.50M | $67.50M | $9.00M | $9.00M | $9.00M | $9.00M | $3.00M | $16.00M | $2.00M | $956.00M | $35.00M | $55.00M | $73.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -86.7% | +0.0% | +0.0% | +0.0% | -66.7% | +433.3% | -87.5% | >999% | -96.3% | +57.1% | +32.7% |
| YoY Change | — | — | — | — | -86.7% | -86.7% | -86.7% | -86.7% | -66.7% | +77.8% | -77.8% | >999% | >999% | +243.8% | >999% |
We use cookies for analytics. See our Privacy and Cookie Policy.